CY1111114T1 - Ανοσοενισχυμενες αντιγονικες μηνιγγιτιδοκοκκικες συνθεσεις - Google Patents
Ανοσοενισχυμενες αντιγονικες μηνιγγιτιδοκοκκικες συνθεσειςInfo
- Publication number
- CY1111114T1 CY1111114T1 CY20111100056T CY111100056T CY1111114T1 CY 1111114 T1 CY1111114 T1 CY 1111114T1 CY 20111100056 T CY20111100056 T CY 20111100056T CY 111100056 T CY111100056 T CY 111100056T CY 1111114 T1 CY1111114 T1 CY 1111114T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antigonic
- immunizable
- mining
- compositions
- microphone
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000005065 mining Methods 0.000 title 1
- 230000003053 immunization Effects 0.000 abstract 2
- 238000002649 immunization Methods 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 201000009906 Meningitis Diseases 0.000 abstract 1
- 241000588653 Neisseria Species 0.000 abstract 1
- 241001212279 Neisseriales Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129007.1A GB0129007D0 (en) | 2001-12-04 | 2001-12-04 | Adjuvanted antigenic meningococcal compositions |
| EP02788442A EP1448230B1 (en) | 2001-12-04 | 2002-12-04 | Adjuvanted antigenic meningococcal compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111114T1 true CY1111114T1 (el) | 2015-06-11 |
Family
ID=9926977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100056T CY1111114T1 (el) | 2001-12-04 | 2011-01-18 | Ανοσοενισχυμενες αντιγονικες μηνιγγιτιδοκοκκικες συνθεσεις |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060008476A1 (enExample) |
| EP (1) | EP1448230B1 (enExample) |
| JP (2) | JP4414226B2 (enExample) |
| AP (1) | AP2004003074A0 (enExample) |
| AT (1) | ATE485055T1 (enExample) |
| AU (1) | AU2002353417A1 (enExample) |
| CA (1) | CA2468935C (enExample) |
| CY (1) | CY1111114T1 (enExample) |
| DE (1) | DE60238075D1 (enExample) |
| GB (1) | GB0129007D0 (enExample) |
| WO (1) | WO2003047619A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| DE60144353D1 (de) * | 2000-02-28 | 2011-05-12 | Novartis Vaccines & Diagnostic | Hybride Expression Neisserscher Proteine |
| CN1977971A (zh) * | 2001-06-07 | 2007-06-13 | 惠氏控股有限公司 | 作为佐剂的霍乱全毒素的突变体形式 |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| EP1506007B1 (en) * | 2002-05-14 | 2011-06-22 | Novartis Vaccines and Diagnostics S.r.l. | Mucosal combination vaccines for bacterial meningitis |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| EP1961426B1 (en) | 2003-10-02 | 2011-04-27 | Novartis Vaccines and Diagnostics S.r.l. | Combined meningitis vaccines |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| CA2756522C (en) | 2009-03-24 | 2018-06-26 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
| SI3831406T1 (sl) | 2010-08-23 | 2024-08-30 | Wyeth Llc | Stabilne formulacije antigenov neisseria meningitidis RLP2086 |
| NZ607224A (en) | 2010-09-10 | 2014-11-28 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
| US20130287808A1 (en) * | 2010-11-05 | 2013-10-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Vaccines for preventing meningococcal infections |
| GB201102090D0 (en) * | 2011-02-08 | 2011-03-23 | Univ Sheffield | Antigenic polypeptide |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| RU2665841C2 (ru) | 2012-03-09 | 2018-09-04 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их применения |
| EP2877492A1 (en) | 2012-07-27 | 2015-06-03 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| EP2964665B1 (en) | 2013-03-08 | 2018-08-01 | Pfizer Inc | Immunogenic fusion polypeptides |
| BR112016004463A2 (pt) | 2013-09-08 | 2017-10-17 | Pfizer | composições de neisseria meningitidis e métodos das mesmas |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CN118021947A (zh) | 2017-01-31 | 2024-05-14 | 辉瑞大药厂 | 脑膜炎奈瑟菌组合物及其使用方法 |
| MX2021007539A (es) * | 2018-12-21 | 2021-09-21 | Univ Griffith | Composiciones, metodos y usos para provocar una respuesta inmune. |
| MX2022003682A (es) | 2019-09-27 | 2022-04-25 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
| US20220348645A1 (en) * | 2019-10-01 | 2022-11-03 | Beth Israel Deaconess Medical Center, Inc. | Conformation-specific antibodies that bind nuclear factor kappa-light-chain-enhancer of activated b cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2671261A1 (en) * | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| BR9906927A (pt) * | 1998-01-14 | 2001-11-20 | Chiron Spa | Proteìnas de neisseria meningitidis |
| PT1117435E (pt) * | 1998-09-30 | 2008-02-21 | Us Gov Univ Health Sciences | Holotoxina da cólera mutante como adjuvante |
| US7384640B1 (en) * | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
-
2001
- 2001-12-04 GB GBGB0129007.1A patent/GB0129007D0/en not_active Ceased
-
2002
- 2002-12-04 US US10/497,709 patent/US20060008476A1/en not_active Abandoned
- 2002-12-04 EP EP02788442A patent/EP1448230B1/en not_active Expired - Lifetime
- 2002-12-04 JP JP2003548874A patent/JP4414226B2/ja not_active Expired - Fee Related
- 2002-12-04 CA CA2468935A patent/CA2468935C/en not_active Expired - Fee Related
- 2002-12-04 DE DE60238075T patent/DE60238075D1/de not_active Expired - Lifetime
- 2002-12-04 AT AT02788442T patent/ATE485055T1/de not_active IP Right Cessation
- 2002-12-04 WO PCT/IB2002/005662 patent/WO2003047619A2/en not_active Ceased
- 2002-12-04 AU AU2002353417A patent/AU2002353417A1/en not_active Abandoned
- 2002-12-04 AP APAP/P/2004/003074A patent/AP2004003074A0/en unknown
-
2009
- 2009-04-10 JP JP2009096521A patent/JP2009155344A/ja not_active Withdrawn
-
2010
- 2010-05-25 US US12/787,366 patent/US20100233205A1/en not_active Abandoned
-
2011
- 2011-01-18 CY CY20111100056T patent/CY1111114T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100233205A1 (en) | 2010-09-16 |
| US20060008476A1 (en) | 2006-01-12 |
| JP2005511662A (ja) | 2005-04-28 |
| GB0129007D0 (en) | 2002-01-23 |
| EP1448230A2 (en) | 2004-08-25 |
| AU2002353417A1 (en) | 2003-06-17 |
| WO2003047619A3 (en) | 2003-10-23 |
| EP1448230B1 (en) | 2010-10-20 |
| ATE485055T1 (de) | 2010-11-15 |
| CA2468935A1 (en) | 2003-06-12 |
| CA2468935C (en) | 2013-02-05 |
| DE60238075D1 (de) | 2010-12-02 |
| WO2003047619A2 (en) | 2003-06-12 |
| AP2004003074A0 (en) | 2004-06-30 |
| JP2009155344A (ja) | 2009-07-16 |
| JP4414226B2 (ja) | 2010-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111114T1 (el) | Ανοσοενισχυμενες αντιγονικες μηνιγγιτιδοκοκκικες συνθεσεις | |
| IL175885A0 (en) | Monovalent antibody fragments useful as therapeutics | |
| CY1106467T1 (el) | Ελεγχομενη συνθεση ζιπρασιδονης | |
| CY1119106T1 (el) | Αντισωματα εναντι masp-2 | |
| CY1115778T1 (el) | Πολλαπλες παραλλαγες της πρωτεϊνης μηνiγγιτιδοκοκκου νμβ1870 | |
| ATE414535T1 (de) | Trägerproteine für impfstoffe | |
| CY1108549T1 (el) | Συνθετικες μεθοδοι για απλιδινη και νεα κατα του ογκου παραγωγα, μεθοδοι κατασκευης και χρησης αυτων | |
| CY1112687T1 (el) | Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες | |
| MXPA05003730A (es) | Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina. | |
| DE60233176D1 (de) | Aus chaperonin-polypeptiden gebildete geordnete biologische nanostrukturen | |
| CY1112507T1 (el) | Μορια αντισωματος που εχουν ειδικοτητα για την ανθρωπινη ιl-1β | |
| CY1109683T1 (el) | Αντιγονα του streptococcus pyogenes | |
| CY1108083T1 (el) | Αντιγονα και συνθεσεις του neisseria meningitidis | |
| ATE481108T1 (de) | Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen | |
| DE60141773D1 (de) | Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren | |
| CY1109888T1 (el) | Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων | |
| SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
| NO20063254L (no) | Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist | |
| ATE355104T1 (de) | Haarbehandlungsmittel | |
| DE50310977D1 (de) | Kompaktiertes menthol | |
| WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
| ITVA20020024A1 (it) | Prodotti per l'edilizia a base di idrossialchilguaro idrofobizzato purificato | |
| TW200517144A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
| ITPN20020022A1 (it) | Motore lineare e compressore azionato da detto motore. | |
| TR200003467T2 (tr) | Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar |